Downstream process development considerations to address polysorbate degradation in drug substance formulation

被引：0
|
作者：
Yigzaw, Yinges [1 ]
Morris, Alex [1 ]
Sawant, Manali [1 ]
Gu, Jie [1 ]
机构：
[1] Genentech Inc, Purificat, San Francisco, CA 94080 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 253卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
163-BIOT
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Impact of Quality by Design in Process Development on the Analytical Control Strategy for a Small-Molecule Drug Substance
    Bryan C. Castle
    Robert A. Forbes
    Journal of Pharmaceutical Innovation, 2013, 8 : 247 - 264
  • [32] Impact of Quality by Design in Process Development on the Analytical Control Strategy for a Small-Molecule Drug Substance
    Castle, Bryan C.
    Forbes, Robert A.
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2013, 8 (04) : 247 - 264
  • [33] Evaluation on the Drug–Polymer Mixing Status in Amorphous Solid Dispersions at the Early Stage Formulation and Process Development
    Hua (May) Ma
    Duk Soon Choi
    Yu-E Zhang
    Hung Tian
    Navnit Shah
    Hitesh P. Chokshi
    Journal of Pharmaceutical Innovation, 2013, 8 : 163 - 174
  • [34] Development and validation of a reverse-phase HPLC method for analysis of efavirenz and its related substances in the drug substance and in a capsule formulation
    Montgomery, ER
    Edmanson, AL
    Cook, SC
    Hovsepian, PK
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 25 (02) : 267 - 284
  • [35] Development, validation and forced degradation studies of green liquid chromatographic method for determination of remdesivir in bulk drug and pharmaceutical formulation
    Samad, Hafiz Abdul
    Ali, Saeeda Nadir
    Qayoom, Amtul
    Haroon, Urooj
    Saad, Muhammad
    Alavi, Ghina Mumtaz
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (01) : 159 - 170
  • [36] Development of a Scalable Manufacturing Process for AB-343 Drug Substance: A Potential Candidate for the Treatment of Coronavirus Infections
    Mason, Jeremy D.
    Spink, Jan M.
    Pallerla, Mahesh
    Wu, Zhenhua
    Singh, Rajeev K.
    Pulipaka, Aravind B.
    Liu, Jia
    Vega, Marvin Marcus
    Wang, Xu
    Sofia, Michael J.
    Pamulapati, Ganapati Reddy
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2025, 29 (03) : 856 - 871
  • [37] Using a Model-based Material Sparing Approach for Formulation and Process Development of a Roller Compacted Drug Product
    Vasudevan, Kalyan V.
    Pu, Yu Elaine
    Amini, Hossein
    Guarino, Catherine
    Agrawal, Anjali
    Akseli, Ilgaz
    PHARMACEUTICAL RESEARCH, 2022, 39 (09) : 2083 - 2093
  • [38] Using a Model-based Material Sparing Approach for Formulation and Process Development of a Roller Compacted Drug Product
    Kalyan V. Vasudevan
    Yu Elaine Pu
    Hossein Amini
    Catherine Guarino
    Anjali Agrawal
    Ilgaz Akseli
    Pharmaceutical Research, 2022, 39 : 2083 - 2093
  • [39] Evaluation on the Drug-Polymer Mixing Status in Amorphous Solid Dispersions at the Early Stage Formulation and Process Development
    Ma, Hua
    Choi, Duk Soon
    Zhang, Yu-E
    Tian, Hung
    Shah, Navnit
    Chokshi, Hitesh P.
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2013, 8 (03) : 163 - 174
  • [40] Application of Ambrx's EuCode p□ technology on making homogeneous ADC drug product: Case studies of downstream process development
    Bai, Yun
    Tuchscherer, Joe
    Atkinson, Kyle
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
12345